Home › Funds › Walsky Investment Management, Inc. › ABT

Walsky Investment Management, Inc. position in ABT

ABBOTT LABORATORIES · Health Care

Walsky Investment Management, Inc. reported holding 21,808 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$2.2M, representing 1.97% of its reported portfolio and ranking #23 among its reported holdings. Walsky Investment Management, Inc. has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)21.81K sh
Reported value held$2.16M
Portfolio Weight1.97%
First reportedQ4 2025
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Walsky Investment Management, Inc.'s ABT position evolved

Walsky Investment Management, Inc. first disclosed a stake in ABT in Q4 2025 at 19,373 shares (US$2.4M). Across 4 filings, Walsky Investment Management, Inc. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 21,808 shares valued at US$2.2M — an increase of 975 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 19.37K $2.43M New
Q1 2026 20.17K $2.07M Add
Q2 2026 20.83K $1.89M Add
Q3 2026 21.81K $2.16M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.65B), Charles Schwab Investment Management (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Walsky Investment Management, Inc. held ABT?

Walsky Investment Management, Inc. has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Walsky Investment Management, Inc.'s current position in ABT?

As of Q3 2026, Walsky Investment Management, Inc. holds 21.81K shares of ABT (ABBOTT LABORATORIES), valued at $2.16M, representing 1.97% of its reported portfolio and ranking #23.

Has Walsky Investment Management, Inc. been buying or selling ABT?

In the latest 13F filing (Q3 2026), Walsky Investment Management, Inc. increased its position in ABT.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Charles Schwab Investment Management, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.